Term
|
Definition
Similar to Cyclosporine
Macrolide antibiotic
Binds FK binding proteins that will inhibit calcineurin
Inhibits IL-3, IL-4, IFN gamma, and TNF-alpha |
|
|
Term
|
Definition
Used in organ transplantation (especially renal, but also heart and liver; increasingly with bone marrow, lung, and pancreas), also for g vs h often in combo with corticosteroids
Also for psoriasis and RA
Topical prep used for atopic dermatitis (eczema) and psoriasis
very often used when other standard treatments have failed |
|
|
Term
|
Definition
Similar to cyclosporine - nephrotoxicity (dose related, caused by vasoconstriction), hypertension, hyperlipidemia, neurotoxicity (paresthesia, tremor, and seizures), and hepatotoxicity
Predisposes patients to viral infection and lymphoma
Often stronger side effects because more potent of a drug than cyclosporine |
|
|
Term
Sirolimus (rapamycin) MOA |
|
Definition
Similar structurally to tacrolimus; also binds FKBP but will inhibit mTOR that would normally phosphate p70 6 kinase and PHAS1 - inhibition of IL-2 stimulated protein synthesis arresting lymphocytes in G1 phase |
|
|
Term
|
Definition
Inhibitor of P450; also metabolized by P450; potential for drug interactions |
|
|
Term
|
Definition
Major: hyperlipidemia, leukopenia, thrombocytopenia, hepatotoxicity, but no nephrotoxicity (patients treated with cyclosporine plus sirolimus have more impaired renal function - pharmacokinetic interaction!) |
|
|
Term
|
Definition
Either use alone or in combination with other agents (cyclosporine and corticosteroids) to prevent rejection of solid organ transplants
Also inhibits proliferation of smooth muscle cells, so can be used in sirolimus-eluting stents |
|
|
Term
Sirolimus used in a renal transplant patient |
|
Definition
Still used in combination with cyclosporine, but the calcineurin inhibitor is at a lower dose plus a glucocorticoid
Levels of drug and kidney function needs to be monitored closely; if someone is at high risk of nephrotoxicity, instead of using cyclosporine with sirolimus, use glucocorticoids and mycophenolate |
|
|
Term
|
Definition
Selective depletion of T cells
Directed towards CD3 - surface protein on helper and cytotoxic T cells; also suppresses T cell responses to transplants
Depletes T cells through antibody mediated activation of complement
|
|
|
Term
|
Definition
Used for preparation and may be used to prevent acute rejection (renal, hepatic, heart)
Some will be used to deplete T cells from donor bone marrow prior to transplantation
Causes profound immunosuppression, but it is transient |
|
|
Term
|
Definition
It's profound
Will first activate T cells before degrading them -- cytokine release syndrome (fever, myalgia, nausea, diarrhea)
Usually occurs after first few doses
It is a mouse anti-human antibody, so body can generate antibodies to it |
|
|
Term
ATG (antithymocyte), ALG (antilymphocyte) |
|
Definition
Raised against human lymphocytes and are polyclonal - will act on long lived peripheral lymphocytes and will have little effect on B cells
Similar uses to OKT 3: suppress T cell mediated response to transplants (used for preparation and acute rejection); some used to deplete T cells from donor bone marrow prior to transplantation |
|
|
Term
|
Definition
Similar to OKT3 - cytokine release syndrome)
But much broader immunossuppression because its polyclonal |
|
|
Term
Anti CD25 mAB, Daclizumab, Basiliximab (chimeric) |
|
Definition
Humanized antibodies against CD25, the IL-2 receptor
This protein is only expressed in activated T cells
Used for induction and in combination with other agents to prevent rejection |
|
|
Term
|
Definition
Inhibition of costimulation
Consists of CLT-4 and will compete CD28 to bind B7
Prevents costimulation |
|
|
Term
In preparation for organ transplant |
|
Definition
Patients may receive immunosuppressive regiment, including; daclizumab, ATG, or anti-CD3 |
|
|
Term
Hyperacute (minutes to hours) and chronic (months to years) |
|
Definition
Cannot be stopped by immunosuppresive drugs
Chronic rejection - activation of T cells - no treatment |
|
|
Term
|
Definition
Weeks to months
Can be treated generally with immunosuppressive drugs
Calcineurin inhibitor (cyclosporine or tacrolimus) PLUS
cell cycle inhibitor (mycophneolate mofetil or sirolimus) PLUS OR MINUS
Steroids |
|
|
Term
|
Definition
Major complication of bone marrow and stem cell transplantation
Start with high dose steroids, add drugs such as mycophenolate mofetil, sirolimus, tacrolimus, daclizumab |
|
|
Term
Immune Globulin Intravenous (IGIV) |
|
Definition
Preparation of IG pooled from a large population of donors: 'normalizing serum'
Used at low doses in humoral deficiency
Use at high doses for severe asthma, some autoimmune disorders, Kawasaki syndrome |
|
|
Term
|
Definition
Concentrated solution of human IgG containing antibodies to Rho(D) antigen of red cell
Prevents sensitization of Rh-negative mother
Administered to mother within 24 to 72 hours after birth of an Rh positive infant |
|
|
Term
Hyperimmune Immunoglobulin |
|
Definition
Made from pools of selected human or animal donors that have ah igh titer to particular antigents such as cytomegalovirus or RSV |
|
|
Term
How to Suppress Immune Response (7 things) |
|
Definition
Inhibit gene expression, block expansion of lymphocytes, inhibit lymphocyte signaling, cytokine inhibition, selective depletion of T cells, Inhibition of co-stimulation, blockade of cell adhesion |
|
|
Term
|
Definition
Downregulate expression of TNF and IL
Inhibit phospholipase A2 leading to decreased eicosanoid production
T cells most affected, but primary antibody response will be diminished and eventually secondary antibody response will be too |
|
|
Term
|
Definition
used in combination with other immunosuppressants for solid organ transplantation and hematopoietic stem cell transplantation and for certain autoimmune diseases - rheumatoid arthritis, SLE
Also used in attenuating allergic reactions |
|
|
Term
|
Definition
Can cause adrenal suppression, so they must be tapered
Other problems are: cushingoid reactions, mood swings, diabeedus, reduced resistance to infection, osteoporosis, cataracts, weight gain, and HTN |
|
|
Term
|
Definition
Pro-drug slowly converted to mercaptopurine nonenzymatically
Slow action helps immunosuppressive activity
Interferes with purine nucleic acid synthesis -- required for lymphoid cell proliferation |
|
|
Term
|
Definition
May be used for kidney transplant and other autoimmune diseases |
|
|
Term
|
Definition
Bone marrow suppression (usually leukopenia) and rash
At higher doses, usually GI effects, some hepatotoxicity |
|
|
Term
Azathioprine Drug Interactions |
|
Definition
With allopurinol - increased levels of drug due to increased levels of 6 mercaptopurine -- too effective in preventing purine synthesis |
|
|
Term
Mycophenolate Mofetil (MMF) MOA |
|
Definition
Also acts by blocking de novo purine synthesis
Inhibits IMPDH (RLS in guanosine synthesis)
Inhibits II form which is more specific for lymphocytes --- less toxic to other cells
Cytostatic effect on lmyphocytes but can also cause apoptosis
Mycophenolate more efficcacious than azathioprine in preventing rejection of kidney transplants; also used for other autoimmune dz |
|
|
Term
|
Definition
GI disturbances, headache, hypertension |
|
|
Term
Other cytotoxic agents used for immunosuppression, but not transplantation |
|
Definition
Methotrexate (rheumatoid arthritis and psoriasis)
Cyclophosphamide (cancers, SLE) |
|
|